Existing and novel Osteoporosis biomarkers, their mechanisms, clinical efficacy, drawbacks, and the best biomarkers in Osteoporosis risk stratification and management are discussed, to convert them into better patient care.
Wasan Nori, Mohammed Jaffer Jawad, Munaf Jarallah Yaseen et al.· AL-Kindy College Medical Jou...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.